Description
Seeking people aged 16 to 80 with moderate to severe ulcerative colitis that is not responding to treatment for a study of an investigational drug.
Overview
Participants in this study will be randomly assigned to get either one of two doses of the investigational drug or a placebo (looks like the investigational drug but contains no medicine) as an injection every two weeks for 12 weeks. After 12 weeks participants may be eligible to continue in a maintenance study.
What we're hoping for
We are studying if investigational drug is safe and reduces symptoms of ulcerative colitis compared to a placebo (looks like the investigational drug but contains no medicine) for people aged 16 to 80 with moderate to severe ulcerative colitis.
Additional Information
ClinicalTrials.gov Identifier: NCT07184996